<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">61880</article-id><article-id pub-id-type="doi">10.17816/kazmj61880</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">On the issue of etiotropic therapy of adenovirus infection in children</article-title><trans-title-group xml:lang="ru"><trans-title>К вопросу этиотропной терапии аденовирусной инфекции у детей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Belogorskaya</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Белогорская</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Professor, Head of the Department of Childhood Diseases, Department of Pharmacology</p></bio><bio xml:lang="ru"><p>Профессор, заведующий кафедрой детских болезней, кафедра фармакологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zaikonnikova</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Заиконникова</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Professor, Head of the Department of Pharmacology, Honored Scientist of the RSFSR, Department of Pharmacology</p></bio><bio xml:lang="ru"><p>Профессор, заведующий кафедрой фармакологии, заслуженный деятель науки РСФСР, кафедра фармакологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rzhevskaya</surname><given-names>G. F.</given-names></name><name xml:lang="ru"><surname>Ржевская</surname><given-names>Г. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Childhood Diseases, Department of Pharmacology</p> <p> </p><p> </p> </bio><bio xml:lang="ru"><p>Кафедра детских болезней, кафедра фармакологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pikuza</surname><given-names>O. I.</given-names></name><name xml:lang="ru"><surname>Пикуза</surname><given-names>О. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Childhood Diseases, Department of Pharmacology</p></bio><bio xml:lang="ru"><p>Кафедра детских болезней, кафедра фармакологии</p></bio><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kazan Order of the Red Banner of Labor Medical Institute S.V. Kurashov</institution></aff><aff><institution xml:lang="ru">Казанский ордена Трудового Красного Знамени медицинский институт им. С. В. Курашова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="1978-07-15" publication-format="electronic"><day>15</day><month>07</month><year>1978</year></pub-date><volume>59</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>14</fpage><lpage>15</lpage><history><date date-type="received" iso-8601-date="2021-02-25"><day>25</day><month>02</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-02-25"><day>25</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1978, Belogorskaya E.V., Zaikonnikova I.V., Rzhevskaya G.F., Pikuza O.I.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1978, Белогорская Е.В., Заиконникова И.В., Ржевская Г.Ф., Пикуза О.И.</copyright-statement><copyright-year>1978</copyright-year><copyright-holder xml:lang="en">Belogorskaya E.V., Zaikonnikova I.V., Rzhevskaya G.F., Pikuza O.I.</copyright-holder><copyright-holder xml:lang="ru">Белогорская Е.В., Заиконникова И.В., Ржевская Г.Ф., Пикуза О.И.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/61880">https://kazanmedjournal.ru/kazanmedj/article/view/61880</self-uri><abstract xml:lang="en"><p>The study of the effectiveness of treatment of patients with adenovirus infection with a new antiviral drug No. 1215 from the group of organophosphorus compounds was carried out. He was prescribed in the form of a 0.1-0.3% solution, 1 teaspoon inside and 2 drops in the nose and conjunctiva 4 times a day. The course of treatment was 7-10 days.</p></abstract><trans-abstract xml:lang="ru"><p>Проведено изучение эффективности лечения больных аденовирусной инфекцией новым противовирусным препаратом № 1215 из группы фосфорорганических соединений. Его назначали в виде 0,1—0,3% раствора по 1 чайной ложке внутрь и по 2 капли в нос и конъюнктиву 4 раза в день. Курс лечения составлял 7—10 дней.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Kazan Medical archive</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Казанский медицинский архив</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Калугина Н. М. В сб.: Фармакология и токсикология фосфорорганических соединений и других биологически активных веществ. Вып. 2, Казань, 1974</mixed-citation></ref></ref-list></back></article>
